Cargando…

Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein

Detalles Bibliográficos
Autores principales:	Uzoeto, Henrietta Onyinye, Ajima, Judith Nnedimkpa, Arazu, Amarachukwu Vivian, Ibiang, Glory Omini, Cosmas, Samuel, Durojaye, Olanrewaju Ayodeji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758984/ https://www.ncbi.nlm.nih.gov/pubmed/35029751 http://dx.doi.org/10.1186/s43141-021-00287-z

Ejemplares similares

An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2020)

Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2020)

An in silico epitope-based peptide vaccine design against the 2019-nCoV
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2020)

Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics
por: Ibiang, Glory Omini, et al.
Publicado: (2022)

Intracellular proteome compartmentalization: a biotin ligase-based proximity labeling approach
por: Durojaye, Olanrewaju Ayodeji
Publicado: (2021)

Characterization of the SARS-CoV-2 coronavirus X4-like accessory protein
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2021)

Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion
por: Salleh, Mohd Zulkifli, et al.
Publicado: (2021)

Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders
por: Odiba, Arome Solomon, et al.
Publicado: (2021)

MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2023)

Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Tang, Haijun, et al.
Publicado: (2021)

In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
por: Çubuk, Hasan, et al.
Publicado: (2022)

The N501Y spike substitution enhances SARS-CoV-2 transmission
por: Liu, Yang, et al.
Publicado: (2021)

501Y.V2 spike protein resists the neutralizing antibody in atomistic simulations
por: Ngo, Son Tung
Publicado: (2022)

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Tang, Haijun, et al.
Publicado: (2021)

Volatile organic compounds: A proinflammatory activator in autoimmune diseases
por: Ogbodo, John Onyebuchi, et al.
Publicado: (2022)

A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans
por: Odiba, Arome Solomon, et al.
Publicado: (2022)

CHAPERONg: A tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses
por: Yekeen, Abeeb Abiodun, et al.
Publicado: (2023)

Preparing for R501
Publicado: (1977)

Año 501 : la conquista continúa /
por: Chomsky, Noam
Publicado: (1993)

The Secret Life of Viral Entry Glycoproteins: Moonlighting in Immune Evasion
por: Cook, Jonathan D., et al.
Publicado: (2013)

The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
por: Postnikova, Olga A., et al.
Publicado: (2021)

Dictionary of 501 Spanish Verbs
por: Kendris, C.
Publicado: (1971)

Clipper 5.01 avanzado /
por: Ramalho, José A.
Publicado: (1992)

Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B
por: Gillet, Laurent, et al.
Publicado: (2007)

HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion
por: Beitari, Saina, et al.
Publicado: (2019)

First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020
por: Fiorentini, Simona, et al.
Publicado: (2021)

CompTIA Security+ SY0-501 review guide: exam SY0-501
por: Stewart, James M
Publicado: (2018)

Scientific Opinion on Flavouring Group Evaluation 501 (FGE.501): Grill flavour concentrate (vegetable)
por: Younes, Maged, et al.
Publicado: (2019)

Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants’ spike protein–an in silico analysis
por: Pokhrel, Suman, et al.
Publicado: (2021)

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

The N501Y Mutation of SARS-CoV-2 Spike Protein Impairs Spindle Assembly in Mouse Oocytes
por: Liu, Huage, et al.
Publicado: (2021)

Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage
por: Colson, Philippe, et al.
Publicado: (2021)

Memorandum: extension of experiment R 501
por: Smith, A
Publicado: (1980)

Evasion of tumours from the control of the immune system: consequences of brief encounters
por: Al-Tameemi, Mohannad, et al.
Publicado: (2012)

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
por: Tian, Fang, et al.
Publicado: (2021)

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
por: Lu, Lu, et al.
Publicado: (2021)

Decreased interfacial dynamics caused by the N501Y mutation in the SARS-Cov-2 s1 spike:ACE2 complex
por: Ahmed, Wesam S., et al.
Publicado: (2022)

Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
por: Cheng, Lin, et al.
Publicado: (2021)

Efficacy of Kigelia africana Lam. (Benth.) leaf and stem bark ethanolic extracts on adult cowpea seed beetle, [Callosobruchus maculatus Fabricius (Coleoptera: Chrysomelidae)] affecting stored cowpea seeds (Vigna unguiculata)
por: Obembe, Olusola Michael, et al.
Publicado: (2020)

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
por: Ghimire, Dibya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_et1skif32km79sjhit8b88ur5e